Peripheral Arterial Disease Clinical Trials in Dallas, Texas

5 studies are recruiting for peripheral arterial disease in Dallas, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries

   This study will test whether using ultrasound imaging within blood vessels during minimally invasive treatment of leg arteries in patients with peripheral artery disease leads to better clinical outcomes.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Baylor Scott & White The Heart Hospital - Dallas, Dallas, Texas

   Locations

   6 in total

   Run by

   Baylor Research Institute

   See if you can join NCT07353905 on ClinicalTrials.gov

2. The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease

   The objective of this prospective, multicenter, randomized, controlled clinical trial is to demonstrate the superiority of the VBX Device for primary patency when compared to bare metal stenting in complex iliac occlusive disease.

   Stage

   Not phased

   Ages

   18 and older

   Site

   The University of Texas Southwestern Medical Center, Dallas, Texas

   Locations

   43 in total

   Run by

   W.L.Gore & Associates

   See if you can join NCT05811364 on ClinicalTrials.gov

3. PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

   A prospective, single-arm, multi-center study designed to gather additional information on the LimFlow System.

   Stage

   Not phased

   Ages

   18 to 95

   Site

   UT Southwestern Medical Center, Dallas, Texas

   Locations

   30 in total

   Run by

   LimFlow, Inc.

   See if you can join NCT05313165 on ClinicalTrials.gov

4. Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

   The Low dose ColchicinE in pAtients with peripheral Artery DiseasE to address residual vascular Risk (LEADER-PAD) trial will evaluate if anti-inflammatory therapy with colchicine will reduce vascular events in patients with symptomatic peripheral artery disease.

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Southwest Family Medicine, Dallas, Texas

   Locations

   70 in total

   Run by

   Population Health Research Institute

   See if you can join NCT04774159 on ClinicalTrials.gov

5. Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes

   XLPAD is an observational study designed to evaluate the effectiveness and use of stent and non-stent based therapies among PAD patients. The study will create a registry that will include entry of procedural and clinical follow-up information into an online data collection software, REDCAP.Data av…

   Stage

   Not phased

   Ages

   Any age

   Site

   North Texas Veteran Affairs Medical Center, Dallas, Texas

   Locations

   24 in total

   Run by

   Baylor Research Institute

   See if you can join NCT01904851 on ClinicalTrials.gov